Published by Frank Prenesti on 11th March 2021
(Sharecast News) - Drug companies GlaxoSmithKline and Vir Biotechnology have been advised to finish a final trial of their Covid-19 drug early due to its "profound efficacy".
URL: http://www.digitallook.com/dl/news/story/31701618/...